Cost-Effectiveness of Adding Bedaquiline to Drug Regimens for the Treatment of Multidrug-Resistant Tuberculosis in the UK

OBJECTIVE: To evaluate the cost-effectiveness of adding bedaquiline to a background regimen (BR) of drugs for multidrug-resistant tuberculosis (MDR-TB) in the United Kingdom (UK). METHODS: A cohort-based Markov model was developed to estimate the incremental cost-effectiveness ratio of bedaquiline p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolfson, Lara J., Walker, Anna, Hettle, Robert, Lu, Xiaoyan, Kambili, Chrispin, Murungi, Andrew, Knerer, Gerhart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368676/
https://www.ncbi.nlm.nih.gov/pubmed/25794045
http://dx.doi.org/10.1371/journal.pone.0120763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368676/
https://www.ncbi.nlm.nih.gov/pubmed/25794045
http://dx.doi.org/10.1371/journal.pone.0120763

Ejemplares similares